358 related articles for article (PubMed ID: 30228048)
1. Fibroblast Growth Factor 21 Is Associated With Bone Mineral Density, but not With Bone Turnover Markers and Fractures in Chinese Postmenopausal Women.
Hu W; He J; Fu W; Wang C; Yue H; Gu J; Zhang H; Zhang Z
J Clin Densitom; 2019; 22(2):179-184. PubMed ID: 30228048
[TBL] [Abstract][Full Text] [Related]
2. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
3. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
Jiajue R; Jiang Y; Qi X; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
[TBL] [Abstract][Full Text] [Related]
4. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
5. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
[TBL] [Abstract][Full Text] [Related]
6. Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study.
Osima M; Borgen TT; Lukic M; Grimnes G; Joakimsen RM; Eriksen EF; Bjørnerem Å
Osteoporos Int; 2018 Feb; 29(2):421-431. PubMed ID: 29134242
[TBL] [Abstract][Full Text] [Related]
7. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
Garnero P; Sornay-Rendu E; Claustrat B; Delmas PD
J Bone Miner Res; 2000 Aug; 15(8):1526-36. PubMed ID: 10934651
[TBL] [Abstract][Full Text] [Related]
8. Mineral bone disorder and osteoporosis in hemodialysis patients.
Slouma M; Sahli H; Bahlous A; Laadhar L; Smaoui W; Rekik S; Gharsallah I; Sallami M; Moussa FB; Elleuch M; Cheour E
Adv Rheumatol; 2020 Feb; 60(1):15. PubMed ID: 32102689
[TBL] [Abstract][Full Text] [Related]
9. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
10. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.
Garnero P; Munoz F; Sornay-Rendu E; Delmas PD
Bone; 2007 Mar; 40(3):716-22. PubMed ID: 17112798
[TBL] [Abstract][Full Text] [Related]
11. Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women.
Wei QS; Huang L; Tan X; Chen ZQ; Chen SM; Deng WM
Scand J Clin Lab Invest; 2016; 76(1):33-9. PubMed ID: 26414945
[TBL] [Abstract][Full Text] [Related]
12. 25-Hydroxyvitamin-D and Bone Turnover Marker Levels in Patients with Distal Radial Fracture.
Rozental TD; Herder LM; Walley KC; Zurakowski D; Coyle K; Bouxsein ML; Wolf JM
J Bone Joint Surg Am; 2015 Oct; 97(20):1685-93. PubMed ID: 26491133
[TBL] [Abstract][Full Text] [Related]
13. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
[TBL] [Abstract][Full Text] [Related]
14. The relationship between fibroblast growth factor 23 and osteoporosis in postmenopausal women.
Celik E; Guzel S; Abali R; Guzelant AY; Celik Guzel E; Kuçukyalcin V
Minerva Med; 2013 Oct; 104(5):497-504. PubMed ID: 24101107
[TBL] [Abstract][Full Text] [Related]
15. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
Jiajue R; Jiang Y; Wang O; Li M; Xing X; Cui L; Yin J; Xu L; Xia W
Osteoporos Int; 2014 Aug; 25(8):1999-2005. PubMed ID: 24760246
[TBL] [Abstract][Full Text] [Related]
16. Associations of Serum Cathepsin K and Polymorphisms in
Gao LH; Li SS; Yue H; Zhang ZL
Front Endocrinol (Lausanne); 2020; 11():48. PubMed ID: 32117071
[TBL] [Abstract][Full Text] [Related]
17. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
Han W; Bai X; Wang N; Han L; Sun X; Chen X
Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the metabolic syndrome and its components and bone status in postmenopausal women.
Fodor D; Vesa S; Albu A; Simon S; Craciun A; Muntean L
Acta Physiol Hung; 2014 Jun; 101(2):216-27. PubMed ID: 24901081
[TBL] [Abstract][Full Text] [Related]
19. Associations of Serum Osteocalcin and Polymorphisms of the Osteocalcin Gene with Bone Mineral Density in Postmenopausal and Elderly Chinese Women.
Zhang XY; He JW; Fu WZ; Liu YJ; Zhang ZL
J Nutrigenet Nutrigenomics; 2016; 9(5-6):231-242. PubMed ID: 28002816
[TBL] [Abstract][Full Text] [Related]
20. Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis.
Mederle OA; Balas M; Ioanoviciu SD; Gurban CV; Tudor A; Borza C
Clin Interv Aging; 2018; 13():1383-1389. PubMed ID: 30122910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
